Back to Search Start Over

Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.

Authors :
Chaisaingmongkol J
Budhu A
Dang H
Rabibhadana S
Pupacdi B
Kwon SM
Forgues M
Pomyen Y
Bhudhisawasdi V
Lertprasertsuke N
Chotirosniramit A
Pairojkul C
Auewarakul CU
Sricharunrat T
Phornphutkul K
Sangrajrang S
Cam M
He P
Hewitt SM
Ylaya K
Wu X
Andersen JB
Thorgeirsson SS
Waterfall JJ
Zhu YJ
Walling J
Stevenson HS
Edelman D
Meltzer PS
Loffredo CA
Hama N
Shibata T
Wiltrout RH
Harris CC
Mahidol C
Ruchirawat M
Wang XW
Source :
Cancer cell [Cancer Cell] 2017 Jul 10; Vol. 32 (1), pp. 57-70.e3. Date of Electronic Publication: 2017 Jun 22.
Publication Year :
2017

Abstract

Intrahepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC) are clinically disparate primary liver cancers with etiological and biological heterogeneity. We identified common molecular subtypes linked to similar prognosis among 199 Thai ICC and HCC patients through systems integration of genomics, transcriptomics, and metabolomics. While ICC and HCC share recurrently mutated genes, including TP53, ARID1A, and ARID2, mitotic checkpoint anomalies distinguish the C1 subtype with key drivers PLK1 and ECT2, whereas the C2 subtype is linked to obesity, T cell infiltration, and bile acid metabolism. These molecular subtypes are found in 582 Asian, but less so in 265 Caucasian patients. Thus, Asian ICC and HCC, while clinically treated as separate entities, share common molecular subtypes with similar actionable drivers to improve precision therapy.<br /> (Published by Elsevier Inc.)

Details

Language :
English
ISSN :
1878-3686
Volume :
32
Issue :
1
Database :
MEDLINE
Journal :
Cancer cell
Publication Type :
Academic Journal
Accession number :
28648284
Full Text :
https://doi.org/10.1016/j.ccell.2017.05.009